Rotavirus-associated acute diarrhea outbreak in West Shewa Zone of Oromia Regional State, Ethiopia, 2017.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2019
Historique:
received: 17 01 2019
accepted: 07 03 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 25 7 2019
Statut: epublish

Résumé

Rotavirus causes severe-diarrheal diseases in infants. An estimation of 138 million rotavirus-associated diarrheal cases and 215,000 deaths occur every year globally. In December 2016, West-Shewa zone in Ethiopia reported unidentified gastrointestinal diarrhea outbreak. We investigated to identify the causative agent of the outbreak to support response operations. Medical records were reviewed, and the daily line list was collected from health facilities. Descriptive data analysis was done by time, person and place. Stool specimens were first tested by antigen capture enzyme immunoassay (EIA) technique and further confirmed by reverse-transcription polymerase chain reaction (RT-PCR) as a gold standard. The product of RT-PCR was genotyped for each gene using G1-G4, G8-G9 and G12 primers for VP7 gene and P(4), P(6), P(8) and P(14) primers for VP4 gene. A total of 1,987 diarrheal cases (5.7 per 1000) and five deaths (case-fatality rate 0.25%) were identified and epidemiologically-linked to confirmed rotavirus from December 2016 to February 2017. Among the cases, 1,946 (98%) were < 5 children. Fourteen (74%) of the 19 tested stool specimens were positive for rotavirus by EIA and RT-PCR. Majority of strains detected were G12P(6) (25%) and G-negative P(8) (25%) followed by G9P(8) (19%), G1P(8) (13%) and G3/G2 P(8), G12P(8), and G-negative P(6) (6% each). Diarrheal outbreak which occurred in West-Shewa zone of Ethiopia was associated with rotavirus and relatively more affected districts with low vaccination coverage. Routine rotavirus vaccination quality and coverage should be evaluated and the surveillance system needs to be strengthened to detect, prevent and control a similar outbreak.

Identifiants

pubmed: 31312314
doi: 10.11604/pamj.2019.32.202.18188
pii: PAMJ-32-202
pmc: PMC6620077
doi:

Substances chimiques

Rotavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Pagination

202

Déclaration de conflit d'intérêts

All Authors declared no competing interests.

Références

J Clin Microbiol. 1992 Jun;30(6):1365-73
pubmed: 1320625
Arch Virol. 2008;153(8):1621-9
pubmed: 18604469
J Infect Dis. 2010 Sep 1;202 Suppl:S34-42
pubmed: 20684715
J Clin Microbiol. 1990 Feb;28(2):276-82
pubmed: 2155916
Arch Virol. 2011 Aug;156(8):1397-413
pubmed: 21597953
Lancet Infect Dis. 2012 Feb;12(2):136-41
pubmed: 22030330
Paediatr Int Child Health. 2012 Feb;32(1):51-5
pubmed: 22525449
Wkly Epidemiol Rec. 2013 Feb 1;88(5):49-64
pubmed: 23424730
Vaccine. 2013 Oct 1;31(42):4902-10
pubmed: 23871824
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S28-33
pubmed: 24343610
BMJ. 2013 Dec 30;347:f7204
pubmed: 24379214
Microbiol Immunol. 2014 Sep;58(9):536-9
pubmed: 25040046
Appl Environ Microbiol. 2014 Nov;80(21):6771-81
pubmed: 25172863
J Clin Microbiol. 2015 Jan;53(1):295-7
pubmed: 25339400
Lancet Infect Dis. 2015 Apr;15(4):422-8
pubmed: 25638521
Emerg Microbes Infect. 2014 Jul;3(7):e47
pubmed: 26038746
Lancet Glob Health. 2016 Feb;4(2):e76-7
pubmed: 26823217
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4092-7
pubmed: 27035949
Aust Fam Physician. 2016 Jan-Feb;45(1):14-6
pubmed: 27051981
Clin Infect Dis. 2016 May 1;62 Suppl 2:S140-6
pubmed: 27059348
Clin Infect Dis. 2016 May 1;62 Suppl 2:S161-7
pubmed: 27059351
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
Emerg Infect Dis. 2016 May;22(5):875-9
pubmed: 27088272
Pediatrics. 2016 Oct;138(4):
pubmed: 27664085
Vaccine. 2018 Nov 12;36(46):7043-7047
pubmed: 30301641
Ethiop Med J. 1986 Jan;24(1):1-6
pubmed: 3943514
Bull World Health Organ. 1981;59(1):67-73
pubmed: 6266682
Appl Environ Microbiol. 1983 Oct;46(4):813-6
pubmed: 6314896
Bull World Health Organ. 1998;76(5):525-37
pubmed: 9868844

Auteurs

Abyot Bekele Woyessa (AB)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Almaz Abebe (A)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Berhane Beyene (B)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Mesfin Tefera (M)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Esete Assefa (E)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Hiwot Ketema (H)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Birke Teshome (B)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Ayenachew Bekele (A)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Yohanis Dugasa (Y)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Shambel Habebe (S)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Zewdu Assefa (Z)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Diriba Sufa (D)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Dagnachew Alemu (D)

Oromia Regional Health Bureau, Addis Ababa, Ethiopia.

Habtamu Tilahun (H)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Mengistu Biru (M)

Center for Public Health Emergency Management, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Gemechu Shume (G)

Oromia Regional Health Bureau, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH